Published in Cancer Weekly, August 21st, 2007
"In this study, we investigated the therapeutic potential of [Lys(40)(Ahx-DTPA-(111)ln)NH2]-Exendin-4, an (111)ln-labeled agonist of GLP-1, in a transgenic mouse model of human insulinoma. Experimental [Lys(40)(Ahx-DTPA-(111)ln) NH2]...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.